{
    "eid": "2-s2.0-85103227507",
    "title": "Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection",
    "cover-date": "2021-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "acute HIV infection",
        "cerebrospinal fluid",
        "cerebrospinal fluid escape",
        "HIV",
        "HIV reservoirs"
    ],
    "authors": [
        "Ryan Handoko",
        "Phillip Chan",
        "Linda Jagodzinski",
        "Suteeraporn Pinyakorn",
        "Sasiwimol Ubolyam",
        "Nittaya Phanuphak",
        "Carlo Sacdalan",
        "Eugene Kroon",
        "Netsiri Dumrongpisutikul",
        "Robert Paul",
        "Victor Valcour",
        "Jintanat Ananworanich",
        "Sandhya Vasan",
        "Serena Spudich"
    ],
    "citedby-count": 7,
    "ref-count": 17,
    "ref-list": [
        "HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment",
        "Defining cerebrospinal fluid HIV RNA escape: Editorial review AIDS",
        "Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells",
        "Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: A longitudinal study",
        "Central nervous system viral invasion and inflammation during acute HIV infection",
        "Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence",
        "Absence of cerebrospinal fluid signs of neuronal injury before and after immediate antiretroviral therapy in acute HIV infection",
        "Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid but not in plasma",
        "Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection",
        "Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification",
        "Neuropsychological impairment in acute HIV and the effect of immediate antiretroviral therapy",
        "Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA",
        "Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load",
        "Distribution of human immunodeficiency virus (HIV) ribonucleic acid in cerebrospinal fluid and blood is linked to CD4/CD8 ratio during acute HIV",
        "Cerebrospinal fluid HIV escape from antiretroviral therapy",
        "The meningeal lymphatic system: A route for HIV brain migration?",
        "Markers of CNS injury in adults living with HIV with CSF HIV not detected vs detected <20copies/ml"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New Haven",
            "@id": "60017994",
            "affilname": "Yale School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rockville",
            "@id": "60014443",
            "affilname": "HJF",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014443",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Silver Spring",
            "@id": "60012786",
            "affilname": "Walter Reed Army Institute of Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012786",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "St. Louis",
            "@id": "60012585",
            "affilname": "Missouri Institute of Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012585",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Amsterdam",
            "@id": "60001157",
            "affilname": "Amsterdam UMC - University of Amsterdam",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001157",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "DOD",
        "National Institute of Mental Health",
        "U.S. National Institute of Allergy and Infectious Disease",
        "Henry M. Jackson Foundation"
    ]
}